Preclinical development of highly effective and safe DNA vaccines directed against HPV 16 E6 and E7.
about
An enhanced heterologous virus-like particle for human papillomavirus type 16 tumour immunotherapy.Design of a highly effective therapeutic HPV16 E6/E7-specific DNA vaccine: optimization by different ways of sequence rearrangements (shuffling).A DNA vaccine encoding mutated HPV58 mE6E7-Fc-GPI fusion antigen and GM-CSF and B7.1.Tumor endothelial marker 1-specific DNA vaccination targets tumor vasculature.The rationale of vectored gene-fusion vaccines against cancer: evolving strategies and latest evidence.Development of a replication-deficient adenoviral vector-based vaccine candidate for the interception of HPV16- and HPV18-induced infections and disease.Antigen design enhances the immunogenicity of Semliki Forest virus-based therapeutic human papillomavirus vaccines.Efficacy Testing of H56 cDNA Tattoo Immunization against Tuberculosis in a Mouse Model.HPV16 E7 DNA tattooing: safety, immunogenicity, and clinical response in patients with HPV-positive vulvar intraepithelial neoplasia.Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases.Potent therapeutic efficacy of an alphavirus replicon DNA vaccine expressing human papilloma virus E6 and E7 antigens
P2860
Q31121276-E29178BB-ECBA-4961-B568-73B85F89EDA6Q34571825-97D80760-FE77-418D-97E2-E89E09C1800AQ36244253-5E51CB1D-D9C1-4C44-88FA-1569A7C814F2Q37679962-434F6351-E4C6-47B3-987F-2A028959FA26Q38206518-C976A9AE-9993-4451-A658-7BC721F28457Q40306609-6790CB81-58C3-4FA9-8AA9-7D36687BCE1EQ42155977-9C3FD2DE-7D49-49ED-96D0-8F58FCDEB0D3Q47221323-D2E27EB9-215A-465F-B635-7B32F76E207BQ47797636-90DF2948-01B7-4784-A6C3-B032C3679E4FQ50115667-C5974AE4-15D8-4299-AB8B-3D6A8FF17F4DQ57138571-11B2A720-B98D-4057-B1C6-BD122A523B53
P2860
Preclinical development of highly effective and safe DNA vaccines directed against HPV 16 E6 and E7.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Preclinical development of hig ...... cted against HPV 16 E6 and E7.
@en
Preclinical development of hig ...... cted against HPV 16 E6 and E7.
@nl
type
label
Preclinical development of hig ...... cted against HPV 16 E6 and E7.
@en
Preclinical development of hig ...... cted against HPV 16 E6 and E7.
@nl
prefLabel
Preclinical development of hig ...... cted against HPV 16 E6 and E7.
@en
Preclinical development of hig ...... cted against HPV 16 E6 and E7.
@nl
P2093
P2860
P356
P1476
Preclinical development of hig ...... cted against HPV 16 E6 and E7.
@en
P2093
John B Haanen
Joost H van den Berg
Koen Oosterhuis
Mireille Toebes
Peter Ohlschläger
Raquel Gomez
Ton N Schumacher
P2860
P304
P356
10.1002/IJC.25894
P577
2011-04-27T00:00:00Z